The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

Dorothy Sorlie, at one point, was afraid her life was coming to an abrupt end. “My husband hadn’t given up, but I did,” said Sorlie. “I thought, ‘Well, this is the way life is.’” From being fairly ...

Osbourne is set to reunite with original bandmates Tony Iommi, Geezer Butler and Bill Ward for a farewell concert in July.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's ...

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...

We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

The renowned musician says he plans to keep playing, after confirming the long-suspected diagnosis.

Star classical conductor and pianist Daniel Barenboim publicly revealed on Thursday that he has been diagnosed with Parkinson ...

The class’ availability online through Zoom is a major feature. With how Parkinson’s can affect movement, and the ability to travel not always guaranteed, having access to pivotal information ...

A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...